Skip to main content

C. R. Bard Aktie - Fundamentalanalyse - Dividendenrendite KGV

Bard C R INC (ISIN: US0673831097, WKN: 856332) Kursdatum: 16.11.2017 Kurs: 334,250 USD
Beschreibung Daten
Symbol BCR
Marktkapitalisierung 25.135.599.616,00 USD
Land Vereinigte Staaten von Amerika
Indizes S&P 500
Sektor Pharma
Rohdaten nach US GAAP in Millionen USD
Aktiensplits 2004-06-01 - 2:1 |
Internet www.crbard.com
Letztes Bilanz Update 13.02.2017

Fundamentaldaten

Fundamental Verhältnisse errechnet am: 16.11.2017
KFCV KCV DIV Rendite GKR EKQ KGV KUV KBV
56,43 45,99 0,30% 9,96 31,57 47,55 6,77 15,01

Firmenbeschreibung

 

 

16.

Unaudited Interim Financial Information

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2016

 

  

1st Qtr

 

  

2nd Qtr

 

  

3rd Qtr

 

  

4th Qtr

 

  

Year

 

 

 

(dollars in millions except per share amounts)

  

 

 

  

 

 

 

 

 

Net sales

 

  

$

873.5

  

  

$

931.5

  

  

$

941.9

  

  

$

967.1

  

  

$

3,714.0

  

 

 

 

Cost of goods

sold

 

  

 

320.4

  

  

 

351.0

  

  

 

352.2

  

  

 

348.1

  

  

 

1,371.7

  

 

 

 

Income from operations

before income taxes

 

  

 

142.9

  

  

 

207.7

  

  

 

112.2

  

  

 

200.9

  

  

 

663.7

  

 

 

 

Net income

 

  

 

116.2

  

  

 

159.2

  

  

 

96.4

  

  

 

159.6

  

  

 

531.4

  

 

 

 

Basic earnings per share

available to common shareholders

 

  

 

1.56

  

  

 

2.14

  

  

 

1.30

  

  

 

2.15

  

  

 

7.15

  

 

 

 

Diluted earnings per

share available to common shareholders

 

  

 

1.54

  

  

 

2.11

  

  

 

1.27

  

  

 

2.11

  

  

 

7.03

  

 

 

 

The first

quarter 2016 included litigation charges of $48.9 million, net

charges from acquisition-related items of $4.5 million primarily

consisting of a purchase accounting adjustment of $5.8 million

associated with the reversal of a liability with respect to certain

revenue-based and manufacturing-related milestones, and

restructuring and productivity initiative costs of $9.8 million.

These items decreased net income by $39.4 million after tax, or

$0.52 diluted earnings per share available to common

shareholders.

 

The second

quarter 2016 included restructuring and productivity initiative

costs of $11.9 million, net charges from acquisition-related items

of $3.9 million primarily consisting of integration costs, and an

asset impairment of $1.2 million. These items decreased net income

by $11.3 million after tax, or $0.15 diluted earnings per share

available to common shareholders.

 

The third

quarter 2016 included litigation charges of $110.6 million,

acquisition-related items of $5.0 million primarily consisting of

integration costs, and restructuring and productivity initiative

costs of $4.6 million. The income tax provision decreased $2.6

million due to the completion of certain IRS examinations. These

items decreased net income by $81.5 million after tax, or $1.08

diluted earnings per share available to common

shareholders.

 

The fourth

quarter 2016 included litigation charges, net, of $45.7 million, a

net benefit from acquisition-related items of $6.8 million

primarily consisting of a benefit of $3.8 million related to

integration costs and a benefit of $3.7 million related to purchase

accounting adjustments, and restructuring and productivity

initiative costs of $4.1 million. These items decreased net income

by $27.6 million after tax, or $0.37 diluted earnings per share

available to common shareholders.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2015

 

  

1st Qtr

 

  

2nd Qtr

 

 

3rd Qtr

 

 

4th Qtr

 

  

Year

 

 

 

(dollars in millions except per share amounts)

  

 

 

  

 

 

 

 

 

Net sales

 

  

$

819.7

  

  

$

859.8

  

 

$

865.7

  

 

$

870.8

  

  

$

3,416.0

  

 

 

 

Cost of goods

sold

 

  

 

311.2

  

  

 

333.7

  

 

 

336.3

  

 

 

320.0

  

  

 

1,301.2

  

 

 

 

Income (loss) from

operations before income taxes

 

  

 

184.6

  

  

 

59.2

  

 

 

(52.4

 

 

158.0

  

  

 

349.4

  

 

 

 

Net income

(loss)

 

  

 

139.8

  

  

 

(54.7

 

 

(86.0

 

 

136.3

  

  

 

135.4

  

 

 

 

Basic earnings (loss) per

share available to common shareholders(A)

 

  

 

1.85

  

  

 

(0.74

 

 

(1.16

 

 

1.82

  

  

 

1.80

  

 

 

 

Diluted earnings (loss)

per share available to common shareholders(A)

 

  

 

1.82

  

  

 

(0.74

)(B) 

 

 

(1.16

)(B) 

 

 

1.79

  

  

 

1.77

  

 

 

 

 

 

 

(A) 

 

Total per share amounts may not add due to rounding.

 

 

 

 

 

(B)

 

Common share equivalents primarily from share-based

compensation plans were not included in the computation of diluted

weighted average shares outstanding because their effect would have

been antidilutive.

 

 

 

 

The first

quarter 2015 included litigation charges of $10.3 million, a net

benefit from acquisition-related items of $9.2 million primarily

consisting of a purchase accounting adjustment of $10.2 million

associated with the reversal of a liability with respect to a

certain revenue-based milestone, and restructuring and productivity

initiative costs of $3.9 million. These items decreased net income

by $2.6 million after tax, or $0.03 diluted earnings per share

available to common shareholders.

 

The second

quarter 2015 included litigation charges, net, of $343.7 million, a

gain of $210.5 million related to the Gore Proceeds, restructuring

and productivity initiative costs of $8.5 million, and net charges

from acquisition-related items of $4.5 million. These items

increased net loss by $209.0 million after tax, or $2.73 diluted

loss per share available to common shareholders.

 

The third

quarter 2015 included litigation charges of $241.1 million,

restructuring and productivity initiative costs of $14.6 million,

and acquisition-related items of $2.5 million primarily consisting

of integration costs. These items increased net loss by $240.5

million after tax, or $3.14 diluted loss per share available to

common shareholders.

 

The fourth

quarter 2015 included net charges from acquisition-related items of

$33.9 million primarily consisting of purchase accounting

adjustments of $24.3 million and integration costs of $5.4 million,

restructuring and productivity initiative costs of $14.5 million,

and an asset impairment of $4.5 million. These items decreased net

income by $28.3 million after tax, or $0.37 diluted earnings per

share available to common shareholders.

 

 

 

Die Finanzoo GmbH übernimmt keine Haftung für die Richtigkeit der Angaben! Alle Angaben sind ohne Gewähr. Quellen: www.bundesanzeiger.de, www.sec.gov, www.crbard.com